| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | 0.087 | 0.006 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | 0.093 | 0.006 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | 0.09 | 0.006 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.12 | 0.007 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.007 |
| mRNA | Vinorelbine | GDSC1000 | pan-cancer | AAC | 0.093 | 0.008 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.097 | 0.008 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | 0.094 | 0.009 |
| mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.093 | 0.009 |
| mRNA | Ispinesib Mesylate | GDSC1000 | pan-cancer | AAC | 0.082 | 0.009 |